Related Experiment Video
Updated: Jul 2, 2025

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
Published on: July 16, 2016
Beta-Cell Tipe1 Orchestrates Insulin Secretion and Cell Proliferation by Promoting Gαs/cAMP Signaling via USP5
Lu Ding1, Yang Sun1, Yan Liang1
1Key Laboratory for Experimental Teratology of Ministry of Education, Shandong Key Laboratory of Infection and Immunity, and Department of Immunology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, P. R. China.
Abstract:
Inadequate β-cell mass and insulin secretion are essential for the development of type 2 diabetes (T2D). TNF-α-induced protein 8-like 1 (Tipe1) plays a crucial role in multiple diseases, however, a specific role in T2D pathogenesis remains largely unexplored. Herein, Tipe1 as a key regulator in T2D, contributing to the maintenance of β cell homeostasis is identified. The results show that the β-cell-specific knockout of Tipe1 (termed Ins2-Tipe1BKO) aggravated diabetic phenotypes in db/db mice or in mice with high-fat diet-induced diabetes. Notably, Tipe1 improves β cell mass and function, a process that depends on Gαs, the α subunit of the G-stimulating protein. Mechanistically, Tipe1 inhibited the K48-linked ubiquitination degradation of Gαs by recruiting the deubiquitinase USP5. Consequently, Gαs or cAMP agonists almost completely restored the dysfunction of β cells observed in Ins2-Tipe1BKO mice. The findings characterize Tipe1 as a regulator of β cell function through the Gαs/cAMP pathway, suggesting that Tipe1 may emerge as a novel target for T2D intervention.
Insights
TNF-α-induced protein 8-like 1 (Tipe1) is crucial for maintaining pancreatic beta cell function and mass. Loss of Tipe1 worsens type 2 diabetes (T2D) by impairing the Gαs/cAMP pathway, highlighting Tipe1 as a potential T2D therapeutic target.
Area of Science:
- Endocrinology
- Molecular Biology
- Metabolic Diseases
Background:
- Type 2 diabetes (T2D) is characterized by inadequate beta-cell mass and function.
- The role of TNF-α-induced protein 8-like 1 (Tipe1) in T2D pathogenesis is largely unknown.
Purpose of the Study:
- To investigate the role of Tipe1 in maintaining beta-cell homeostasis and its potential contribution to T2D.
- To elucidate the molecular mechanisms by which Tipe1 regulates beta-cell function.
Main Methods:
- Beta-cell-specific knockout of Tipe1 (Ins2-Tipe1BKO) in mouse models of diabetes (db/db and high-fat diet-induced).
- Analysis of beta-cell mass, function, and molecular pathways involving Gαs, ubiquitination, and cAMP signaling.
Main Results:
- Tipe1 deficiency in beta cells aggravated diabetic phenotypes in mice.
- Tipe1 was found to enhance beta-cell mass and function by stabilizing Gαs protein levels.
- Tipe1 inhibits K48-linked ubiquitination and degradation of Gαs via recruitment of USP5.
- Restoration of Gαs or cAMP levels ameliorated beta-cell dysfunction in Tipe1-deficient mice.
Conclusions:
- Tipe1 is a critical regulator of beta-cell function and homeostasis in the context of T2D.
- The Gαs/cAMP pathway is essential for Tipe1's protective effects on beta cells.
- Tipe1 represents a promising novel therapeutic target for T2D intervention.
Related Concept Videos
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Insulin Secretory Vesicles
cAMP-dependent Protein Kinase Pathways
Cell Specific Gene Expression
Insulin: The Receptor and Signaling Pathways
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...

